We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$433B
AUM Growth
+$39.3B
Cap. Flow
+$6.99B
Cap. Flow %
1.61%
Top 10 Hldgs %
19.86%
Holding
3,573
New
35
Increased
2,384
Reduced
635
Closed
102

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.16B
2
HSY icon
Hershey
HSY
+$663M
3
LMT icon
Lockheed Martin
LMT
+$622M
4
MO icon
Altria Group
MO
+$525M
5
PFE icon
Pfizer
PFE
+$499M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.76B
2
MRK icon
Merck
MRK
+$2.35B
3
ADP icon
Automatic Data Processing
ADP
+$1.57B
4
BX icon
Blackstone
BX
+$1.38B
5
ITW icon
Illinois Tool Works
ITW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 12.71%
3 Healthcare 11.72%
4 Consumer Discretionary 10.09%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YHGJ icon
3401
Yunhong Green CTI Ltd
YHGJ
$7.54M
$32.1K ﹤0.01%
2,021
BEAT icon
3402
Heartbeam
BEAT
$27.8M
$31.7K ﹤0.01%
14,543
OPRT icon
3403
Oportun Financial
OPRT
$255M
$31.7K ﹤0.01%
13,044
TYGO icon
3404
Tigo Energy
TYGO
$145M
$31.5K ﹤0.01%
29,427
+940
+3% +$1.3K
CVM icon
3405
CEL-SCI Corp
CVM
$20.3M
$31.5K ﹤0.01%
549
LL
3406
DELISTED
LL Flooring Holdings, Inc.
LL
$31.4K ﹤0.01%
17,182
-927,613
-98% -$2.24M
ZDGE icon
3407
Zedge
ZDGE
$38.6M
$31.4K ﹤0.01%
11,319
BNGO icon
3408
Bionano Genomics
BNGO
$12.3M
$31.1K ﹤0.01%
467
CLSD
3409
DELISTED
Clearside Biomedical
CLSD
$30.9K ﹤0.01%
1,348
ELDN icon
3410
Eledon Pharmaceuticals
ELDN
$261M
$30.9K ﹤0.01%
14,987
ALGS icon
3411
Aligos Therapeutics
ALGS
$26.2M
$30.8K ﹤0.01%
1,255
LPTV
3412
DELISTED
Loop Media, Inc.
LPTV
$30.5K ﹤0.01%
83,321
USIO icon
3413
Usio Inc
USIO
$58.8M
$30.2K ﹤0.01%
17,787
SUP
3414
DELISTED
Superior Industries International
SUP
$30K ﹤0.01%
10,350
BDSX icon
3415
Biodesix
BDSX
$220M
$29.5K ﹤0.01%
1,031
HYFM icon
3416
Hydrofarm Holdings
HYFM
$2.57M
$29.3K ﹤0.01%
2,715
PDYN icon
3417
Palladyne AI
PDYN
$247M
$29.2K ﹤0.01%
16,115
REFR icon
3418
Research Frontiers
REFR
$14M
$28.4K ﹤0.01%
21,870
CRVS icon
3419
Corvus Pharmaceuticals
CRVS
$1.12B
$27.9K ﹤0.01%
15,668
DYAI icon
3420
Dyadic International
DYAI
$38.3M
$27.3K ﹤0.01%
16,336
XPL icon
3421
Solitario Resources
XPL
$68.3M
$26.9K ﹤0.01%
44,899
ORKA
3422
Oruka Therapeutics
ORKA
$5.82B
$26.7K ﹤0.01%
1,249
HOOK
3423
DELISTED
HOOKIPA Pharma
HOOK
$25.8K ﹤0.01%
3,629
CDTX
3424
DELISTED
Cidara Therapeutics
CDTX
$24.7K ﹤0.01%
1,341
CLIR icon
3425
ClearSign Technologies
CLIR
$24.3M
$24.7K ﹤0.01%
2,556

Similar funds

Charles Schwab's Q1 2024 Portfolio in Review

As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
  • Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
  • Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
  • Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
  • Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.